H-AIIRILQQL-OH
Ref. 3D-PP45870
| 1mg | 217.00 € | ||
| 10mg | 253.00 € | ||
| 100mg | 455.00 € |
Product Information
- NH2-Ala-Ile-Ile-Arg-Ile-Leu-Gln-Gln-Leu-OH
Peptide H-AIIRILQQL-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-AIIRILQQL-OH include the following: Supplemental Table 1. List of HIV class I peptides. M End - pdfs.semanticscholar.orghttps://pdfs.semanticscholar.org/ed0f/0f087694817c860c5aad97fab618403c2847.pdf The majority of currently circulating human immunodeficiency virus type 1 clade B viruses fail to prime cytotoxic T-lymphocyte responses against an otherwise M Altfeld, TM Allen , ET Kalife, N Frahm - Journal of , 2005 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/jvi.79.8.5000-5005.2005 Vpr is preferentially targeted by CTL during HIV-1 infection M Altfeld, MM Addo , RL Eldridge, XG Yu - The Journal of , 2001 - journals.aai.orghttps://journals.aai.org/jimmunol/article/167/5/2743/34449 Vpr Is Preferentially Targeted by CTL CB Kalams, PJR Goulder , S Eric - J Immunol, 2001 - researchgate.nethttps://www.researchgate.net/profile/Marylyn-Addo/publication/11835014_Vpr_is_preferentially_targeted_by_CTL_during_HIV-1_infection/links/0deec520823df5fe25000000/Vpr-is-preferentially-targeted-by-CTL-during-HIV-1-infection.pdf
Chemical properties
Technical inquiry about: 3D-PP45870 H-AIIRILQQL-OH
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
